The path for medical associations to sponsor trustworthy guidelines: is it feasible?
| dc.contributor.author | Pagano, Domenico | |
| dc.contributor.author | Home, Philip | |
| dc.contributor.author | Irs, Alar | |
| dc.contributor.author | Ledermann, Jonathan | |
| dc.contributor.author | Curigliano, Giuseppe | |
| dc.contributor.author | Iwatani, Tsuguo | |
| dc.contributor.author | Mandrola, John | |
| dc.contributor.author | Freemantle, Nick | |
| dc.date.accessioned | 2024-02-07T14:01:43Z | |
| dc.date.available | 2024-02-07T14:01:43Z | |
| dc.date.issued | 2022-04-29 | |
| dc.identifier.citation | Pagano D, Home P, Irs A, Ledermann J, Curigliano G, Iwatani T, Mandrola J, Freemantle N. The path for medical associations to sponsor trustworthy guidelines: is it feasible? J R Soc Med. 2022 Jul;115(7):252-256. doi: 10.1177/01410768221095240. Epub 2022 Apr 29. | en_US |
| dc.identifier.issn | 0141-0768 | |
| dc.identifier.eissn | 1758-1095 | |
| dc.identifier.doi | 10.1177/01410768221095240 | |
| dc.identifier.pmid | 35485430 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14200/3571 | |
| dc.description.abstract | No abstract available | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | SAGE Publications | en_US |
| dc.relation.url | https://journals.sagepub.com/home/jrs | en_US |
| dc.subject | Cardiology | en_US |
| dc.subject | Oncology. Pathology. | en_US |
| dc.subject | Surgery | en_US |
| dc.subject | Biochemistry | en_US |
| dc.title | The path for medical associations to sponsor trustworthy guidelines: is it feasible? | en_US |
| dc.type | Article | |
| dc.source.journaltitle | Journal of the Royal Society of Medicine | |
| dc.source.volume | 115 | |
| dc.source.issue | 7 | |
| dc.source.beginpage | 252 | |
| dc.source.endpage | 256 | |
| dc.source.country | England | |
| rioxxterms.version | NA | en_US |
| oa.grant.openaccess | na | en_US |